Sort   by:  
 Page size 
UnknownAPOE4 homozygote females are resistant to the beneficial effects of 17β-estradiol on memory and CA1 dendritic spine density in the EFAD mouse model of Alzheimer's disease.
Not available
S-EPMC10756028 | biostudies-literature
UnknownAlzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How.
Not available
S-EPMC7150653 | biostudies-literature
UnknownGenetics ignite focus on microglial inflammation in Alzheimer's disease.
Not available
S-EPMC4595327 | biostudies-literature
UnknownMetabolomic analysis of a selective ABCA1 inducer in obesogenic challenge provides a rationale for therapeutic development.
Not available
S-EPMC8010624 | biostudies-literature
UnknownAPOE genotype and sex affect microglial interactions with plaques in Alzheimer's disease mice.
Not available
S-EPMC6528326 | biostudies-literature
UnknownAssessing Schmallenberg Virus Disease in Sardinia (Italy) After the First Epidemic Episode in 2012.
Not available
S-EPMC12030605 | biostudies-literature
UnknownNeuronal pentraxin 1: A synaptic-derived plasma biomarker in Alzheimer's disease.
Not available
S-EPMC8092920 | biostudies-literature
UnknownA small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer's disease mouse model.
Not available
S-EPMC6279743 | biostudies-literature
UnknownThe detrimental effects of APOE4 on risk for Alzheimer's disease may result from altered dendritic spine density, synaptic proteins, and estrogen receptor alpha.
Not available
S-EPMC8976726 | biostudies-literature
UnknownMurine Gut Microbiome Association With APOE Alleles.
Not available
S-EPMC7034241 | biostudies-literature
Sort   by:  
 Page size